Makers Laboratories (506919.BO) Stock Price

Makers Laboratories Price

CLOSED
181.60
​
Market closed

Over the last 14 years Makers Laboratories grew revenue by 5.9% annually, reaching 1.40 B INR. Earnings per share have declined at 1.7% per year over the last 13 years. For Makers Laboratories, the net margin of 1.7% is down versus 3.9% a few years ago. At today's price the dividend yield works out to roughly 0.53%. The payout ratio is around 18% of earnings.

Makers Laboratories stock price

Access this data via the Eulerpool API

Makers Laboratories business model & stock analysis

Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 121 full-time employees. The firm is engaged in the manufacturing and marketing of pharmaceuticals. The firm operates through the pharmaceuticals segment. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range) and Exylin (Amoxycillin range). Its Inspira retail packs division includes acid regulatory (PPIS), anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensives, and others. Its Experia bulk packs division includes amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and others.

Frequently asked questions about Makers Laboratories

5 analysts currently rate the Makers Laboratories stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Makers Laboratories share trades at 1.68 EUR (181.60 INR).

The revenue of Makers Laboratories is 1.40 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Makers Laboratories is 23.51 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Makers Laboratories is currently 45.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Makers Laboratories stock.

The price-to-sales ratio (P/S) of Makers Laboratories is currently 0.77. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Makers Laboratories stock.

The Eulerpool Quality Score for Makers Laboratories is 5/10.

The ISIN of Makers Laboratories is INE987A01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Makers Laboratories is 506919.BO. The ticker symbol is used to trade Makers Laboratories shares on the stock exchange.

Fair ValueTerminal
187.05 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
11.53 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jul 13, 1993
ISIN
INE987A01010
Cusip
Y54191112
Market capitalization
1.07 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.22
P/B Ratio
1.47
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.18 %
Dividend
Dividend yield
0.00 %
Payout Ratio
19.78 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 10, 2026, 10:14 PM

Makers Laboratories Peer Group

Makers Laboratories FIGI

MAKR:IN · BBG000CW2BG1MAKR:IB · BBG000CW2C97